HASTINGS PAUL J Insider Trading
Get the latest insider transactions of HASTINGS PAUL J. HASTINGS PAUL J is President & CEO in QLT INC/BC ($QLTI) and Chairman & CEO in OncoMed Pharmaceuticals Inc ($OMED) and Chief Executive Officer in OncoMed Pharmaceuticals Inc ($OMED) and Director in PROTEON THERAPEUTICS INC ($PRTO) and Director in Pacira Pharmaceuticals, Inc. ($PCRX) and Director in Relypsa Inc ($RLYP) and Chief Executive Officer in Nkarta, Inc. ($NKTX) and See Remarks in Nkarta, Inc. ($NKTX). Discover the current value of HASTINGS PAUL J shares.
Address: 887 GREAT NORTHERN WAY VANCOUVER, BRITISH COLUMBIA V5T 4T5
HASTINGS PAUL J is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
NVLN | NOVELION THERAPEUTICS INC. | President & CEO | 9,500 | 18,525.00 |
PCRX | Pacira BioSciences, Inc. | Director | 6,552 | 273,546.00 |
RLYP | Relypsa Inc | Director | 2,250 | 0.00 |
OMED | OncoMed Pharmaceuticals Inc | Chairman & CEO, Chief Executive Officer | 77,534 | 634,228.12 |
TARA | Protara Therapeutics, Inc. | Director | 0 | 0.00 |
NKTX | Nkarta, Inc. | Chief Executive Officer, See Remarks | 241,600 |
Insider Trading Transactions of HASTINGS PAUL J
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Jun 11 2021 | PCRX | Pacira BioSciences, Inc. | HASTINGS PAUL J | Director | Buy | 0.00 | 1,066 | 0 | 6,552 |
Jun 11 2021 | PCRX | Pacira BioSciences, Inc. | HASTINGS PAUL J | Director | Option Exercise | 60.96 | 7,626 | 464,881 | 7,626 |
Apr 01 2021 | NKTX | Nkarta, Inc. | HASTINGS PAUL J | Chief Executive Offic ... | Sell | 30.23 | 11,461 | 346,466 | 241,600 |
Apr 01 2021 | NKTX | Nkarta, Inc. | HASTINGS PAUL J | Chief Executive Offic ... | Sell | 31.24 | 2,409 | 75,257 | 239,191 |
Apr 01 2021 | NKTX | Nkarta, Inc. | HASTINGS PAUL J | Chief Executive Offic ... | Sell | 32.21 | 3,130 | 100,817 | 236,061 |
Mar 09 2021 | PCRX | Pacira BioSciences, Inc. | HASTINGS PAUL J | Director | Buy | 13.98 | 3,000 | 41,940 | 9,116 |
Mar 09 2021 | PCRX | Pacira BioSciences, Inc. | HASTINGS PAUL J | Director | Sell | 65.88 | 3,000 | 197,640 | 6,116 |
Mar 09 2021 | PCRX | Pacira BioSciences, Inc. | HASTINGS PAUL J | Director | Option Exercise | 13.98 | 3,000 | 41,940 | 0 |
Jan 12 2021 | NKTX | Nkarta, Inc. | HASTINGS PAUL J | Chief Executive Offic ... | Option Exercise | 54.89 | 157,500 | 8,645,175 | 157,500 |
Jul 13 2020 | NKTX | Nkarta, Inc. | HASTINGS PAUL J | See Remarks | Option Exercise | 18.00 | 202,400 | 3,643,200 | 202,400 |
Jul 13 2020 | NKTX | Nkarta, Inc. | HASTINGS PAUL J | See Remarks | Option Exercise | 18.00 | 202,400 | 3,643,200 | 202,400 |
Jun 11 2020 | PCRX | Pacira BioSciences, Inc. | HASTINGS PAUL J | Director | Buy | 0.00 | 1,260 | 0 | 6,116 |
Jun 11 2020 | PCRX | Pacira BioSciences, Inc. | HASTINGS PAUL J | Director | Option Exercise | 47.65 | 8,027 | 382,487 | 8,027 |
Jun 08 2020 | PCRX | Pacira BioSciences, Inc. | HASTINGS PAUL J | Director | Sell | 47.46 | 2,025 | 96,107 | 4,856 |
Jun 06 2019 | PCRX | Pacira BioSciences, Inc. | HASTINGS PAUL J | Director | Sell | 42.66 | 782 | 33,360 | 2,747 |
Jun 06 2019 | PCRX | Pacira BioSciences, Inc. | HASTINGS PAUL J | Director | Buy | 0.00 | 4,134 | 0 | 6,881 |
Jun 06 2019 | PCRX | Pacira BioSciences, Inc. | HASTINGS PAUL J | Director | Option Exercise | 43.54 | 8,437 | 367,347 | 8,437 |
Jun 06 2019 | PCRX | Pacira BioSciences, Inc. | HASTINGS PAUL J | Director | Sell | 42.66 | 782 | 33,360 | 2,747 |
Jun 06 2019 | PCRX | Pacira BioSciences, Inc. | HASTINGS PAUL J | Director | Buy | 0.00 | 4,134 | 0 | 6,881 |
Jun 06 2019 | PCRX | Pacira BioSciences, Inc. | HASTINGS PAUL J | Director | Option Exercise | 43.54 | 8,437 | 367,347 | 8,437 |
Jun 15 2018 | PCRX | Pacira Pharmaceuticals, I ... | HASTINGS PAUL J | Director | Buy | 0.00 | 782 | 0 | 3,529 |
Jun 15 2018 | PCRX | Pacira Pharmaceuticals, I ... | HASTINGS PAUL J | Director | Option Exercise | 38.35 | 4,693 | 179,977 | 4,693 |
Jun 11 2018 | PRTO | PROTEON THERAPEUTICS INC | HASTINGS PAUL J | Director | Option Exercise | 2.50 | 12,700 | 31,750 | 12,700 |
Jun 06 2018 | PCRX | Pacira Pharmaceuticals, I ... | HASTINGS PAUL J | Director | Sell | 33.90 | 771 | 26,137 | 2,747 |
Oct 12 2017 | OMED | OncoMed Pharmaceuticals I ... | HASTINGS PAUL J | Chairman & CEO | Sell | 4.26 | 52 | 222 | 77,534 |
Oct 12 2017 | OMED | OncoMed Pharmaceuticals I ... | HASTINGS PAUL J | Chairman & CEO | Sell | 4.24 | 1,346 | 5,709 | 76,188 |
Aug 24 2017 | PCRX | Pacira Pharmaceuticals, I ... | HASTINGS PAUL J | Director | Sell | 36.15 | 1,044 | 37,741 | 3,518 |
Jun 21 2017 | PRTO | PROTEON THERAPEUTICS INC | HASTINGS PAUL J | Director | Option Exercise | 1.30 | 6,666 | 8,666 | 6,666 |
Jun 16 2017 | PCRX | Pacira Pharmaceuticals, I ... | HASTINGS PAUL J | Director | Buy | 0.00 | 1,357 | 0 | 4,562 |
Jun 16 2017 | PCRX | Pacira Pharmaceuticals, I ... | HASTINGS PAUL J | Director | Option Exercise | 44.20 | 2,714 | 119,959 | 2,714 |
Apr 25 2017 | OMED | OncoMed Pharmaceuticals I ... | HASTINGS PAUL J | Chairman & CEO | Buy | 0.00 | 45,000 | 0 | 77,586 |
Apr 25 2017 | OMED | OncoMed Pharmaceuticals I ... | HASTINGS PAUL J | Chairman & CEO | Option Exercise | 3.77 | 135,000 | 508,950 | 135,000 |
Apr 05 2017 | OMED | OncoMed Pharmaceuticals I ... | HASTINGS PAUL J | Chairman & CEO | Sell | 8.87 | 48 | 426 | 39,011 |
Apr 05 2017 | OMED | OncoMed Pharmaceuticals I ... | HASTINGS PAUL J | Chairman & CEO | Sell | 9.06 | 6,425 | 58,199 | 32,586 |
Jan 09 2017 | OMED | OncoMed Pharmaceuticals I ... | HASTINGS PAUL J | Chairman & CEO | Buy | 1.43 | 21,369 | 30,558 | 58,692 |
Jan 09 2017 | OMED | OncoMed Pharmaceuticals I ... | HASTINGS PAUL J | Chairman & CEO | Sell | 8.17 | 21,369 | 174,602 | 37,323 |
Jan 09 2017 | OMED | OncoMed Pharmaceuticals I ... | HASTINGS PAUL J | Chairman & CEO | Buy | 1.43 | 21,369 | 30,558 | 58,692 |
Jan 09 2017 | OMED | OncoMed Pharmaceuticals I ... | HASTINGS PAUL J | Chairman & CEO | Sell | 8.52 | 21,369 | 181,957 | 37,323 |
Jan 09 2017 | OMED | OncoMed Pharmaceuticals I ... | HASTINGS PAUL J | Chairman & CEO | Option Exercise | 1.43 | 21,369 | 30,558 | 21,369 |
Jan 09 2017 | OMED | OncoMed Pharmaceuticals I ... | HASTINGS PAUL J | Chairman & CEO | Option Exercise | 1.43 | 21,369 | 30,558 | 0 |
Jan 05 2017 | OMED | OncoMed Pharmaceuticals I ... | HASTINGS PAUL J | Chairman & CEO | Option Exercise | 7.66 | 176,000 | 1,348,160 | 176,000 |
Oct 20 2016 | PRTO | PROTEON THERAPEUTICS INC | HASTINGS PAUL J | Director | Option Exercise | 9.00 | 13,333 | 119,997 | 13,333 |
Oct 11 2016 | OMED | OncoMed Pharmaceuticals I ... | HASTINGS PAUL J | Chairman & CEO | Buy | 0.00 | 14,000 | 0 | 37,323 |
Sep 02 2016 | RLYP | Relypsa Inc | HASTINGS PAUL J | Director | Sell | 32.00 | 2,495 | 79,840 | 2,250 |
Sep 02 2016 | RLYP | Relypsa Inc | HASTINGS PAUL J | Director | Sell | 32.00 | 2,250 | 72,000 | 0 |
Sep 02 2016 | RLYP | Relypsa Inc | HASTINGS PAUL J | Director | Option Exercise | 3.96 | 21,802 | 86,336 | 0 |
Sep 02 2016 | RLYP | Relypsa Inc | HASTINGS PAUL J | Director | Option Exercise | 7.40 | 15,953 | 118,052 | 0 |
Sep 02 2016 | RLYP | Relypsa Inc | HASTINGS PAUL J | Director | Option Exercise | 23.96 | 3,828 | 91,719 | 0 |
Sep 02 2016 | RLYP | Relypsa Inc | HASTINGS PAUL J | Director | Option Exercise | 35.79 | 4,500 | 161,055 | 0 |
Sep 02 2016 | RLYP | Relypsa Inc | HASTINGS PAUL J | Director | Option Exercise | 17.00 | 4,500 | 76,500 | 0 |
Jun 23 2016 | RLYP | Relypsa Inc | HASTINGS PAUL J | Director | Buy | 0.00 | 2,250 | 0 | 4,745 |
Jun 23 2016 | RLYP | Relypsa Inc | HASTINGS PAUL J | Director | Option Exercise | 17.00 | 4,500 | 76,500 | 4,500 |
Jun 17 2016 | PCRX | Pacira Pharmaceuticals, I ... | HASTINGS PAUL J | Director | Buy | 0.00 | 1,488 | 0 | 3,205 |
Jun 17 2016 | PCRX | Pacira Pharmaceuticals, I ... | HASTINGS PAUL J | Director | Option Exercise | 40.34 | 2,975 | 120,012 | 2,975 |
Jun 08 2016 | RLYP | Relypsa Inc | HASTINGS PAUL J | Director | Sell | 19.32 | 1,013 | 19,573 | 2,495 |
Jun 08 2016 | PCRX | Pacira Pharmaceuticals, I ... | HASTINGS PAUL J | Director | Sell | 46.95 | 1,136 | 53,335 | 1,717 |
Feb 22 2016 | PCRX | Pacira Pharmaceuticals, I ... | HASTINGS PAUL J | Director | Buy | 13.98 | 2,000 | 27,960 | 4,853 |
Feb 22 2016 | PCRX | Pacira Pharmaceuticals, I ... | HASTINGS PAUL J | Director | Buy | 10.81 | 1,000 | 10,810 | 5,853 |
Feb 22 2016 | PCRX | Pacira Pharmaceuticals, I ... | HASTINGS PAUL J | Director | Sell | 60.00 | 3,000 | 180,000 | 2,853 |
Feb 22 2016 | PCRX | Pacira Pharmaceuticals, I ... | HASTINGS PAUL J | Director | Option Exercise | 13.98 | 2,000 | 27,960 | 3,000 |
Feb 22 2016 | PCRX | Pacira Pharmaceuticals, I ... | HASTINGS PAUL J | Director | Option Exercise | 10.81 | 1,000 | 10,810 | 0 |
Jan 08 2016 | OMED | OncoMed Pharmaceuticals I ... | HASTINGS PAUL J | Chairman & CEO | Sell | 22.30 | 2,335 | 52,072 | 22,102 |
Jan 08 2016 | OMED | OncoMed Pharmaceuticals I ... | HASTINGS PAUL J | Chairman & CEO | Sell | 21.54 | 77 | 1,659 | 22,025 |
Dec 29 2015 | OMED | OncoMed Pharmaceuticals I ... | HASTINGS PAUL J | Chief Executive Offic ... | Option Exercise | 21.43 | 170,000 | 3,643,100 | 170,000 |
Nov 24 2015 | PCRX | Pacira Pharmaceuticals, I ... | HASTINGS PAUL J | Director | Buy | 10.81 | 3,000 | 32,430 | 5,853 |
Nov 24 2015 | PCRX | Pacira Pharmaceuticals, I ... | HASTINGS PAUL J | Director | Sell | 60.00 | 3,000 | 180,000 | 2,853 |
Nov 24 2015 | PCRX | Pacira Pharmaceuticals, I ... | HASTINGS PAUL J | Director | Option Exercise | 10.81 | 3,000 | 32,430 | 1,000 |
Aug 19 2015 | PCRX | Pacira Pharmaceuticals, I ... | HASTINGS PAUL J | Director | Buy | 10.81 | 3,000 | 32,430 | 5,853 |
Aug 19 2015 | PCRX | Pacira Pharmaceuticals, I ... | HASTINGS PAUL J | Director | Sell | 60.02 | 3,000 | 180,060 | 2,853 |
Aug 19 2015 | PCRX | Pacira Pharmaceuticals, I ... | HASTINGS PAUL J | Director | Option Exercise | 10.81 | 3,000 | 32,430 | 4,000 |
Jun 15 2015 | RLYP | Relypsa Inc | HASTINGS PAUL J | Director | Sell | 34.63 | 1,454 | 50,359 | 3,508 |
Jun 08 2015 | RLYP | Relypsa Inc | HASTINGS PAUL J | Director | Buy | 0.00 | 2,250 | 0 | 4,962 |
Jun 08 2015 | RLYP | Relypsa Inc | HASTINGS PAUL J | Director | Option Exercise | 35.79 | 4,500 | 161,055 | 4,500 |
Jun 05 2015 | PCRX | Pacira Pharmaceuticals, I ... | HASTINGS PAUL J | Director | Buy | 0.00 | 2,000 | 0 | 2,853 |
Jun 05 2015 | PCRX | Pacira Pharmaceuticals, I ... | HASTINGS PAUL J | Director | Option Exercise | 79.43 | 4,000 | 317,720 | 4,000 |
Apr 14 2015 | PCRX | Pacira Pharmaceuticals, I ... | HASTINGS PAUL J | Director | Buy | 13.98 | 2,500 | 34,950 | 3,353 |
Apr 14 2015 | PCRX | Pacira Pharmaceuticals, I ... | HASTINGS PAUL J | Director | Sell | 88.00 | 2,500 | 220,000 | 853 |
Apr 14 2015 | PCRX | Pacira Pharmaceuticals, I ... | HASTINGS PAUL J | Director | Option Exercise | 13.98 | 2,500 | 34,950 | 5,000 |
Apr 29 2005 | QLTI | QLT INC/BC | HASTINGS PAUL J | President & CEO | Buy | 10.77 | 900 | 9,693 | 9,500 |
Mar 10 2005 | QLTI | QLT INC/BC | HASTINGS PAUL J | President & CEO | Option Exercise | 12.45 | 100,000 | 1,245,000 | 100,000 |